Rapid Therapeutic Science Laboratories, Inc. RTSL 0.07 Rapid Therapeutic Science Laboratories, Inc.

Home
  /  
Stock List  /  Rapid Therapeutic Science Laboratories, Inc.
Range:0.001-0.009Vol Avg:10506Last Div:0Changes:0
Beta:-11.6Cap:0.00BCurrency:USDExchange:PNK
Sector:HealthcareIPO:Wed Jun 14 2017Empoloyees:3
CUSIP:753431105CIK:0001575659ISIN:US7534312043Country:US
CEO:Mr. Donal R. Schmidt Jr.Website:https://www.rtslco.com
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow